V. Schuermans

613 total citations
13 papers, 499 citations indexed

About

V. Schuermans is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, V. Schuermans has authored 13 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Pediatrics, Perinatology and Child Health and 3 papers in Epidemiology. Recurrent topics in V. Schuermans's work include Antifungal resistance and susceptibility (3 papers), Nail Diseases and Treatments (3 papers) and Pharmaceutical studies and practices (3 papers). V. Schuermans is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), Nail Diseases and Treatments (3 papers) and Pharmaceutical studies and practices (3 papers). V. Schuermans collaborates with scholars based in Belgium. V. Schuermans's co-authors include J Brugmans, D. Thienpont, H. Verhaegen, W. De Cock, J. Symoens, H. Scheijgrond, I. van Wijngaarden, J. Heykants, Piet De Doncker and Harry Goyvaerts and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Life Sciences.

In The Last Decade

V. Schuermans

13 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. Schuermans Belgium	10	174	155	82	49	47	13	499
Richard J. Fetchick United States	9	321 1.8×	382 2.5×	112 1.4×	38 0.8×	36 0.8×	10	549
Brian Dickson United States	10	132 0.8×	61 0.4×	82 1.0×	77 1.6×	56 1.2×	22	588
R. Lissner Germany	14	69 0.4×	243 1.6×	180 2.2×	16 0.3×	86 1.8×	46	659
P. Van Rooy Belgium	9	446 2.6×	402 2.6×	92 1.1×	75 1.5×	78 1.7×	18	879
Paulo Câmara Marques Pereira Brazil	14	281 1.6×	167 1.1×	39 0.5×	38 0.8×	93 2.0×	60	666
Richard Allan United Kingdom	14	80 0.5×	61 0.4×	62 0.8×	38 0.8×	105 2.2×	39	661
A.A. Poltera Switzerland	15	292 1.7×	92 0.6×	57 0.7×	10 0.2×	52 1.1×	38	722
B. C. Tennant United States	14	165 0.9×	43 0.3×	63 0.8×	13 0.3×	48 1.0×	19	489
Sumio Kawamura Japan	11	290 1.7×	304 2.0×	51 0.6×	32 0.7×	67 1.4×	22	586
C. R. Gregg United States	8	151 0.9×	83 0.5×	25 0.3×	22 0.4×	36 0.8×	10	365

Countries citing papers authored by V. Schuermans

Since Specialization

Citations

This map shows the geographic impact of V. Schuermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Schuermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Schuermans more than expected).

Fields of papers citing papers by V. Schuermans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Schuermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Schuermans. The network helps show where V. Schuermans may publish in the future.

Co-authorship network of co-authors of V. Schuermans

This figure shows the co-authorship network connecting the top 25 collaborators of V. Schuermans. A scholar is included among the top collaborators of V. Schuermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Schuermans. V. Schuermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Schuermans, V., et al.. (1993). Meta-Analysis of the Global Evaluation of Levocabastine Nasal Spray versus Placebo. Drug Information Journal. 27(2). 575–584. 2 indexed citations

2.

Schuermans, V., et al.. (1987). International Drug Registration Efforts. The Journal of Clinical Pharmacology. 27(4). 253–259. 2 indexed citations

3.

Cauwenbergh, G., et al.. (1987). Itraconazole in the Treatment of Human Mycoses: Review of Three Years of Clinical Experience. Clinical Infectious Diseases. 9(Supplement_1). S146–S152. 76 indexed citations

4.

Schuermans, V., et al.. (1986). Thirty‐three years of drug discovery and research with Dr. Paul Janssen. Drug Development Research. 8(1-4). 1–13. 13 indexed citations

5.

Symoens, J., et al.. (1980). An Evaluation of Two Years of Clinical Experience with Ketoconazole. Clinical Infectious Diseases. 2(4). 674–691. 108 indexed citations

6.

Moens, Maarten, et al.. (1978). Levamisole in Ascariasis. American Journal of Tropical Medicine and Hygiene. 27(5). 897–904. 6 indexed citations

7.

Verhaegen, H., et al.. (1974). The Arteriolar Effects of Cinnarizine and Flunarizine. Angiology. 25(4). 261–278. 28 indexed citations

8.

Crée, J. De, et al.. (1974). IMPAIRED NEUTROPHIL PHAGOCYTOSIS. The Lancet. 304(7875). 294–295. 36 indexed citations

9.

Brugmans, J, et al.. (1973). PROLACTIN, PHENOTHIAZINES, ADMISSION TO MENTAL HOSPITAL, AND CARCINOMA OF THE BREAST. The Lancet. 302(7827). 502–503. 16 indexed citations

10.

Brugmans, J, V. Schuermans, W. De Cock, et al.. (1973). Restoration of host defense mechanisms in man by levamisole. Life Sciences. 13(11). 1499–1504. 53 indexed citations

11.

Brugmans, J, J. Van Cutsem, J. Heykants, V. Schuermans, & D. Thienpont. (1972). Systemic antifungal potential, safety, biotransport and transformation of micronazole nitrate. European Journal of Clinical Pharmacology. 5(2). 93–99. 66 indexed citations

12.

Janssen, Paul, et al.. (1972). An International Double‐Blind Clinical Evaluation of Pimozide. PubMed. 12(1). 26–34. 15 indexed citations

13.

Brugmans, J, D. Thienpont, I. van Wijngaarden, et al.. (1971). Mebendazole in enterobiasis. Radiochemical and pilot clinical study in 1,278 subjects.. PubMed. 217(3). 313–6. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact